Your body gets vitamin D from three sources: the sun, food, and supplements. There are only a few foods that provide vitamin ...

Braveheart Bio (BRVE) looks undervalued in late-stage HCM with funded Phase 3 trials, strong cash runway and nHCM upside.

Rutaecarpine is touted as a fix to rapidly flush caffeine out of the body, but it may be toxic when mixed with Tylenol ...

It's a VR revolution for the ages, so come check out the 8 best VR mods you need to try right now.

Immunovant's IMVT-1402 aims to deliver best-in-class FcRn inhibition, but mixed data tempers confidence in its superiority.

KRAS- and ALK-driven lung cancer models, supporting mutation-agnostic development as monotherapy and in combination with established ...

Two randomized crossover trials found equivalent systemic exposure for test and reference nebulized budesonide in healthy ...

HER3‑targeted PET imaging demonstrated tumor uptake and retention, supporting ATNM‑400's potential to deliver sustained alpha radiation to tumors over a timeframe consistent with Actinium‑225's 10-day ...

The grand historical drama «Half-Life» is already being called the main series of the year — its premiere on the Okko service ...

DAC in peptides is a group that binds a compound to albumin so it clears more slowly. Here's how CJC-1295 with DAC differs ...

Hepion Pharmaceuticals completes the Gravitas Life Sciences acquisition, creating a three-program portfolio across therapeutics and diagnostics.

A Duke University-led team reports proof-of-concept evidence that a closed-loop PID control algorithm can automatically ...